Coherus BioSciences Earnings Preview: Analysts Estimate $-0.15 EPS, Shares Down 53.6% Over Last 52 Weeks.

Coherus BioSciences (CHRS) is set to announce its quarterly earnings on Monday, May 12. Analysts estimate an EPS of $-0.15. The company's EPS missed by $0.15 in the last quarter, leading to a 0.96% increase in share price. Shares are down 53.6% over the last 52 weeks. Long-term shareholders are likely upset going into this earnings release.